United States (US) Irritable Bowel Syndrome (IBS) Market (2025-2031) | Outlook, Forecast, Segmentation, Growth, Size & Revenue, Analysis, Industry, Companies, Competitive Landscape, Share, Trends, Value

Market Forecast By Drug Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Others), By Medical Condition (IBS-Constipation, IBS-diarrhea, Mixed), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By End-Users (Hospitals, Clinics, Homecare Settings) And Competitive Landscape
Product Code: ETC9968610 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Irritable Bowel Syndrome (IBS) Market Outlook
  • Market Size of United States (US) Irritable Bowel Syndrome (IBS) Market, 2024
  • Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market, 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Revenues & Volume for the Period 2021- 2031
  • United States (US) Irritable Bowel Syndrome (IBS) Market Trend Evolution
  • United States (US) Irritable Bowel Syndrome (IBS) Market Drivers and Challenges
  • United States (US) Irritable Bowel Syndrome (IBS) Price Trends
  • United States (US) Irritable Bowel Syndrome (IBS) Porter's Five Forces
  • United States (US) Irritable Bowel Syndrome (IBS) Industry Life Cycle
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Drug Type for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Lubiprostone for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Linaclotide for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Eluxadoline for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Rifaximin for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Alosetron for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Medical Condition for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By IBS-Constipation for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By IBS-diarrhea for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Mixed for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Hospital Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Online Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Retail Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By End-Users for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Homecare Settings for the Period 2021- 2031
  • United States (US) Irritable Bowel Syndrome (IBS) Import Export Trade Statistics
  • Market Opportunity Assessment By Drug Type
  • Market Opportunity Assessment By Medical Condition
  • Market Opportunity Assessment By Distribution Channel
  • Market Opportunity Assessment By End-Users
  • United States (US) Irritable Bowel Syndrome (IBS) Top Companies Market Share
  • United States (US) Irritable Bowel Syndrome (IBS) Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Irritable Bowel Syndrome (IBS) Company Profiles
  • United States (US) Irritable Bowel Syndrome (IBS) Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?
6Wresearch actively monitors the United States (US) Irritable Bowel Syndrome (IBS) Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Irritable Bowel Syndrome (IBS) Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Do you also provide customisation in the market study?
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Irritable Bowel Syndrome (IBS) Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Irritable Bowel Syndrome (IBS) Market - Industry Life Cycle

3.4 United States (US) Irritable Bowel Syndrome (IBS) Market - Porter's Five Forces

3.5 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.6 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Medical Condition, 2021 & 2031F

3.7 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

3.8 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By End-Users, 2021 & 2031F

4 United States (US) Irritable Bowel Syndrome (IBS) Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness and diagnosis rates of irritable bowel syndrome (IBS) in the United States.

4.2.2 Growing demand for effective IBS treatments and therapies.

4.2.3 Technological advancements in diagnostic tools and treatment options for IBS patients.

4.3 Market Restraints

4.3.1 Lack of definitive diagnostic tests for IBS, leading to misdiagnosis and delayed treatment.

4.3.2 High cost associated with specialized IBS treatments and therapies.

4.3.3 Regulatory challenges and stringent approval processes for new IBS medications.

5 United States (US) Irritable Bowel Syndrome (IBS) Market Trends

6 United States (US) Irritable Bowel Syndrome (IBS) Market, By Types

6.1 United States (US) Irritable Bowel Syndrome (IBS) Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Drug Type, 2021- 2031F

6.1.3 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Lubiprostone, 2021- 2031F

6.1.4 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Linaclotide, 2021- 2031F

6.1.5 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Eluxadoline, 2021- 2031F

6.1.6 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Rifaximin, 2021- 2031F

6.1.7 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Alosetron, 2021- 2031F

6.1.8 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Irritable Bowel Syndrome (IBS) Market, By Medical Condition

6.2.1 Overview and Analysis

6.2.2 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-Constipation, 2021- 2031F

6.2.3 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-diarrhea, 2021- 2031F

6.2.4 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Mixed, 2021- 2031F

6.3 United States (US) Irritable Bowel Syndrome (IBS) Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.3.3 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

6.3.4 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.4 United States (US) Irritable Bowel Syndrome (IBS) Market, By End-Users

6.4.1 Overview and Analysis

6.4.2 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Homecare Settings, 2021- 2031F

7 United States (US) Irritable Bowel Syndrome (IBS) Market Import-Export Trade Statistics

7.1 United States (US) Irritable Bowel Syndrome (IBS) Market Export to Major Countries

7.2 United States (US) Irritable Bowel Syndrome (IBS) Market Imports from Major Countries

8 United States (US) Irritable Bowel Syndrome (IBS) Market Key Performance Indicators

8.1 Patient-reported outcomes (PROs) related to symptom improvement and quality of life after treatment.

8.2 Adoption rates of emerging digital health solutions for IBS management.

8.3 Number of clinical trials and research studies focused on developing novel IBS treatments.

8.4 Healthcare provider adherence to clinical guidelines for IBS diagnosis and treatment.

8.5 Patient adherence and compliance rates with prescribed IBS treatments and therapies.

9 United States (US) Irritable Bowel Syndrome (IBS) Market - Opportunity Assessment

9.1 United States (US) Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.2 United States (US) Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Medical Condition, 2021 & 2031F

9.3 United States (US) Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

9.4 United States (US) Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By End-Users, 2021 & 2031F

10 United States (US) Irritable Bowel Syndrome (IBS) Market - Competitive Landscape

10.1 United States (US) Irritable Bowel Syndrome (IBS) Market Revenue Share, By Companies, 2024

10.2 United States (US) Irritable Bowel Syndrome (IBS) Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Related Report Available


×
Go to New Report No! I want to read this
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
Buy Now
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Search

Related Reports

Industry Events and Analyst Meet

4th Edition India Energy Conclave 2025

4th Edition India Energy Conclave 2025

Media Expo 2025

Media Expo 2025

Gas India Expo 2025

Gas India Expo 2025

Consumer Electronics World Expo 2025

Consumer Electronics World Expo 2025

Gifts World Expo 2025

Gifts World Expo 2025

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All

6WResearch In News

Read All
About Us

6Wresearch is the premier, one stop market intelligence and advisory center, known for its best in class business research and consulting activity. We provide industry research reports and consulting service across different industries and geographies which provide industry players an in-depth coverage and help them in decision making before investing or enter into a particular geography.

  • twitter logo
  • facebook logo
  • linkedin logo
Company
About Us
Events
Careers
Privacy Policy
Terms & Conditions
Delivery
Disclaimer
Contact Us
Services
ADVISORY & CONSULTING
FEASIBILITY STUDIES & BUSINESS PLAN
COMPETITORS INTELLIGENCE
CHANNEL & DISTRIBUTION STRATEGY
PROCUREMENT INTELLIGENCE
CUSTOMER BEHAVIOR ANALYSIS
BUSINESS MODELS & KEY MANAGEMENT PRACTICES
CRITICAL SUCCESS FACTORS ANALYSIS
Verticals
Aerospace and Defense
Chemicals and Materials
Semiconductor and Electronics
Power, Utility and Oil & Gas
Heavy Industry
Telecom, Information & Communication Technology
Healthcare
Automotive
Consumer Staples
Banking, Financial and Legal Services
Metals and Minerals
Media and Entertainment
Miscellaneous
©2025 6Wresearch, All Right Reserved